phentermine has been researched along with Abnormalities, Drug-Induced in 2 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Controlled prospective cohort study comparing 98 women who had taken phentermine/fenfluramine to 233 women who had not, all of whom contacted the California Teratogen Information Service during pregnancy." | 7.71 | Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine. ( Chambers, CD; Dick, LM; Felix, RJ; Johnson, KA; Jones, KL; Kao, KK, 2002) |
| "Controlled prospective cohort study comparing 98 women who had taken phentermine/fenfluramine to 233 women who had not, all of whom contacted the California Teratogen Information Service during pregnancy." | 3.71 | Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine. ( Chambers, CD; Dick, LM; Felix, RJ; Johnson, KA; Jones, KL; Kao, KK, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colman, E | 1 |
| Golden, J | 1 |
| Roberts, M | 1 |
| Egan, A | 1 |
| Weaver, J | 1 |
| Rosebraugh, C | 1 |
| Jones, KL | 1 |
| Johnson, KA | 1 |
| Dick, LM | 1 |
| Felix, RJ | 1 |
| Kao, KK | 1 |
| Chambers, CD | 1 |
2 other studies available for phentermine and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
The FDA's assessment of two drugs for chronic weight management.
Topics: Abnormalities, Drug-Induced; Anti-Obesity Agents; Benzazepines; Delayed-Action Preparations; Drug Ap | 2012 |
Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Appetite Depressants; Cohort Studies; Drug Thera | 2002 |